|
FAM168A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25319999991314E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.62200000495017E-08 |
| Normal-vs-Stage2 |
7.478700E-03 |
| Normal-vs-Stage3 |
1.193620E-02 |
| Normal-vs-Stage4 |
8.135600E-03 |
| Stage1-vs-Stage2 |
4.796200E-01 |
| Stage1-vs-Stage3 |
3.396400E-01 |
| Stage1-vs-Stage4 |
5.526400E-01 |
| Stage2-vs-Stage3 |
9.075800E-01 |
| Stage2-vs-Stage4 |
3.427000E-01 |
| Stage3-vs-Stage4 |
3.403000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3026999996254E-07 |
| Normal-vs-AfricanAmerican |
6.62259999950621E-07 |
| Normal-vs-Asian |
1.825580E-04 |
| Caucasian-vs-AfricanAmerican |
5.009800E-01 |
| Caucasian-vs-Asian |
3.714000E-01 |
| AfricanAmerican-vs-Asian |
4.422000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01139999708622E-08 |
| Normal-vs-Female |
1.611170E-01 |
| Male-vs-Female |
1.449440E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.610400E-04 |
| Normal-vs-Extreme_Weight |
1.01590003076524E-09 |
| Normal-vs-Obese |
1.420820E-03 |
| Normal-vs-Extreme_Obese |
2.33439999999252E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.111800E-01 |
| Normal_Weight-vs-Obese |
3.017400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.601800E-01 |
| Extreme_Weight-vs-Obese |
6.538900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.955800E-01 |
| Obese-vs-Extreme_Obese |
1.565410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.088630E-01 |
| Normal-vs-Age(41-60Yrs) |
6.41169999999747E-05 |
| Normal-vs-Age(61-80Yrs) |
1.59590000103904E-08 |
| Normal-vs-Age(81-100Yrs) |
1.82469999998602E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.646000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.084800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.361370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.548100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.147900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.42069997380412E-09 |
| Normal-VS-Type2 PRCC |
2.03890000000095E-05 |
| Normal-VS-KIRP CIMP |
8.826400E-01 |
| Normal-VS-Unclassified PRCC |
3.118200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.411420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.007810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.957700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.271500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.015900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.020400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30470000025973E-07 |
| Normal-vs-N1 |
2.534100E-02 |
| Normal-vs-N2 |
5.188800E-01 |
| N0-vs-N1 |
2.832800E-01 |
| N0-vs-N2 |
3.487800E-01 |
| N1-vs-N2 |
8.628600E-01 |
|
|
